
Keywords: 2â²OMePS; 2â²-O-methyl phosphorothioate; 2â²MOE-PS; 2â²-O-methoxyethyl phosphorothioate; AON; antisense oligonucleotide; CPP; cell-penetrating peptide; DMD; Duchenne muscular dystrophy; PMO; phosphorodiamidate morpholino; PPMO; peptide-conjugated phos